Good morning everyone! This "Week in Review" is going to be brief as there wasn't too much activity this week. Additionally, Matthew is working on an educational piece for the week ahead and I am going to put the finishing touches on a research report that I know will be interesting for everyone. We will also be working on some research for a few companies on our Watch List.
And I am rushing out the door for my youngest daughter's 3rd birthday party! How quickly the years fly by...
Brief Discussion of some of our Portfolio Companies:
Xpel Technologies (XPEL, DAP.U-V): Xpel announced Q2 earnings before the open on Monday. I think we all know what has happened to the stock since then. Matthew posted an update for members explaining that the drop was due to the company coming short of the 50% growth in revenue target by coming in at 35%. However, upon further digestion the 35% growth was impacted by a huge currency related shortfall. If you haven't done so already, please read Matthew's update; it's a great read.
Ackroo (AKR.V): Ackroo announced its uplisting in the US to the OTC markets to better support its growing American sharebase. This is always a good thing and it goes to the heart of the shareholder friendly practices of Ackroo. It's no secret that Matthew and I are a big fan of the CEO. As the stock continues to be under pressure, likely from some warrant holders selling around the .25 warrant level, I continue to add to my position. I sent out a note to members stating that I had a conversation with the CEO and he mentioned he purchased 100,000 warrants from a shareholder and is encouraging other insiders to make some purchases as well. This will be out soon publicly as he reported it shortly before notifying me. Matthew and I are both very optimistic about the future of Ackroo, and clearly is Steve Levely, the CEO.
Microbix (MBX.TO): Microbix traded a little better this week reaching about $.475 during the week. As the company mentioned in their last earnings report, they are potentially close to signing a Letter of Intent (LOI) with a partner to help commercialize their Kinlytic product. I suspect that some long term investors are adding to their position in advance of this potential announcement.
Beamz (BZIC): I am continuing to work on this research piece. It has been a little delayed as I was afforded the opportunity by the CEO to sign a NDA to be able to view material that contains the company's future business plan and financial projections that are being provided to potential large investors interested in the current private placement. While I will not be able to disclose anything I learn from the documents, there is plenty I already know that leads me to believe that this is the best "Special Situation" stock/company I have ever come across. I look forward to sharing the report with you later this week.
As always, Matthew and I appreciate any feedback that you have to offer. And, of course, any member referrals would be highly appreciated!
Have a great Sunday!